JHJulia Höfler

Julia Höfler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Höfler has a total of 82 co-authors. Here are the top co-authors by number of shared publications:

  • Eugen Trinka

    Department of Neurology, Neurocritical Care, and Neurorehabilitation, Center for Cognitive Neuroscience, Member of European Reference Network EpiCARE Christian Doppler University Hospital, Paracelsus Medical University Salzburg Austria

    12 shared publications
  • Giorgi Kuchukhidze

    Department of Neurology, Neurocritical Care, and Neurorehabilitation Christian Doppler University Hospital, member of European Reference Network EpiCARE, and Center for Cognitive Neuroscience, Paracelsus Medical University Salzburg Austria

    8 shared publications
  • Bernardo Crespo Pimentel

    Department of Neurology, Neurocritical Care and Neurorehabilitation, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Member of the European Reference Network EpiCARE, Paracelsus Medical University of Salzburg, 5020 Salzburg, Austria

    6 shared publications
  • Lucas Rainer

    Department of Neurology, Neurocritical Care, and Neurorehabilitation Christian‐Doppler University Hospital, Paracelsus Medical University, Center for Cognitive Neuroscience Salzburg, member of European Reference Network EpiCARE Salzburg Austria

    5 shared publications
  • Gudrun Kalss

    Department of Neurology, Neurocritical Care, and Neurorehabilitation, Center for Cognitive Neuroscience, Member of European Reference Network EpiCARE Christian Doppler University Hospital, Paracelsus Medical University Salzburg Austria

    4 shared publications
  • Markus Leitinger

    Department of Neurology, Neurocritical Care and Neurorehabilitation Christian Doppler University Hospital, Centre of Cognitive Neuroscience, Paracelsus Medical University, Member of EpiCARE Salzburg Austria

    4 shared publications

Latest Publications

  • Open Access

    Theory of mind: A cognitive endophenotype of juvenile myoclonic epilepsy?

    by Bernardo Crespo‐Pimentel, Lucas J. Rainer, Mario Braun, Martin Kronbichler, Patrick Langthaler, Lisa Kronbichler, Sarah Said‐Yürekli, Laura Zamarian, Hennric Jokeit, Kornelius Winds, et al.

    Objective: Juvenile myoclonic epilepsy (JME), the most common idiopathic generalized epilepsy, is associated with neuropsychological and psychiatric comorbidities, including social cognition and theory of mind (ToM) deficits. The interplay between clinical features, social cognition, and their neural and genetic substrates remains poorly understood. We investigated social cognition in individuals with JME and their unaffected siblings to explore its potential as a disease endophenotype. Methods: In this prospective cross‐sectional study, 52 individuals with JME (age = 29 ± 11 years, 56% female), 13 unaffected siblings (age = 26 ± 7 years, 38% female), and 64 healthy controls (age = 28 ± 11 years, 55% female) completed neuropsychological tests and self‐report questionnaires assessing social cognition. Test scores were assigned to previously defined theoretical social cognition domains and averaged into domain‐specific composite z ‐scores. Participants underwent functional magnetic resonance imaging using a ToM paradigm. Social cognition performance was compared between groups, and associations with clinical variables were explored. Results: Compared with healthy controls, individuals with JME showed reduced performance in tasks requiring mentalizing about beliefs (e.g., Faux Pas Test, Reading the Mind in the Eyes Test). Domain‐level analyses confirmed selective impairment in mentalizing about beliefs, whereas other ToM components showed no consistent group differences. Unaffected siblings did not differ significantly from either individuals with JME or healthy controls on any measure. Significance: Our study aligns with previous literature expanding the extent of ToM impairment in individuals with JME. An endophenotypic role of ToM in JME could not be established in the present sample and remains a hypothesis to be tested in adequately powered studies.

  • Open Access

    Neural correlates of Obsessive – Compulsive Personality Traits in Juvenile Myoclonic Epilepsy

    by Lucas J Rainer, Bernardo Crespo Pimentel, Eugen Trinka, Giorgi Kuchukhidze, Mario Braun, Martin Kronbichler, Patrick Langthaler, Kornelius Winds, Georg Zimmermann, Lisa Kronbichler, et al.

    Objective: To delineate the phenotype of juvenile myoclonic epilepsy (JME) with a focus on obsessive–compulsive personality disorder (OCPD) using multimodal psychiatric, neuropsychological, quantitative EEG (qEEG), and structural MRI markers within a predictive-processing/free-energy framework. Methods: We prospectively studied 65 patients with JME and 68 matched healthy controls (HC). Participants completed DSM-IV SCID I/II interviews and a neuropsychological battery assessing working memory, psychomotor speed, mental flexibility, divided attention, inhibition, and phasic/tonic alertness; standard EEG and high-resolution structural MRI were acquired. Groups comprised HC and JME subgroups without psychiatric comorbidity, with non-OCPD Axis I/II diagnoses, and with OCPD. Welch’s t-tests (FDR-corrected) and Hedges’ g quantified neuropsychological and alpha-band coherence differences. Surface-based analyses assessed cortical thickness/surface area. Exploratory regressions tested associations of OCPD, seizure freedom, and antiseizure medication (ASM) load with cognition; Kendall’s tau tested coherence–cognition associations. Results: Compared with HC, JME showed broad executive–attentional impairment, most pronounced in patients with psychiatric comorbidity. The OCPD subgroup exhibited particularly large slowing in psychomotor speed, inhibition (reaction time), and tonic alertness versus HC, while OCPD versus non-OCPD JME differences did not survive multiple-comparison correction. qEEG showed increased interhemispheric frontal and decreased temporal alpha coherence in JME, with temporal hypo-coherence strongest in those with psychiatric comorbidity; within JME, OCPD was linked to increased left fronto-temporal alpha coherence. In the MRI subsample, JME-OCPD demonstrated increased cortical thickness in left medial orbitofrontal and anterior cingulate regions (vs HC and vs JME without OCPD) and additional posterior occipito-temporal clusters versus HC. Regression and coherence–cognition associations were weak and non-significant after FDR correction. Significance: JME features syndrome-level executive–attentional dysfunction and altered fronto–temporal network organization. Comorbid OCPD marks a subgroup with accentuated cognitive slowing and distinct medial prefrontal/cingulate structural and left fronto-temporal connectivity signatures, aligning with predictive-processing accounts of rigid, over-precise high-level priors. Key points: JME is linked to broad executive–attentional impairment versus healthy controls. Psychiatric comorbidity amplifies cognitive deficits in JME. JME with OCPD shows particularly large slowing/inhibitory-control deficits versus controls, while OCPD vs non-OCPD differences within JME are modest. Alpha-band EEG coherence indicates altered network organization in JME and an OCPD-related increase in left fronto–temporal coherence within JME Surface-based MRI suggests an OCPD-related structural phenotype in JME, involving medial orbitofrontal/anterior cingulate cortical thickening

  • Open Access

    Epilepsy and employment: A qualitative interview study with heads of human resources and occupational physicians in Austria — A call for legislative optimization according to the WHO Intersectoral Global Action Plan

    by Markus Leitinger, Claudia Klampfer, Leonie Obermeyr, Kateriine Orav, Payam Tabaee Damavandi, Michael Alexa, Aljoscha Thomschewski, Julia Höfler, Fabio Rossini, Giorgi Kuchukhidze, et al.

    Objective: People with epilepsy (PWEs) often face difficulties in obtaining or keeping employment. To determine the views on this topic of the heads of human resources (HHRs) and occupational physicians (OCPs). Method: Twelve HHRs and five OCPs underwent a telephone interview concerning the opportunities and limitations of job applications for PWEs. The interviews were performed in May 2020, in the federal state of Salzburg, Austria, and they were analyzed using the qualitative method of content analysis (Kuckartz). The legal situation was investigated according to Global target 5.2 of the Intersectoral Global Action Plan (IGAP) on epilepsy and other neurological disorders 2022–2031 by WHO. Results: Employers were confident that employees with epilepsy could be managed well in a positive company culture and with first responders in place. The Austrian law predisposes to uncertainty among both employers and employees. In particular, it allows only retrospective juridical clarification of health‐related questions in the job interview. The authors developed a classification system of workplaces, with “D0” (D‐zero) meaning no health or financial danger, for example, office workers and “D1” posing still no health hazard but includes regular work with cash, for example, salespersons. “D2” means potential medical implications for the person with epilepsy or any other person at the workplace, for example, industrial worker. Measures taken to abandon the risk in D2 workplaces, for example, a total sheath for a machine, leads to reclassification as “D2‐0.” With D2, OCPs evaluate the applicant's medical fitness for the job without disclosing medical details to the employer. The “compartment model of medical information in the job application process” guarantees that OCPs are the only persons who learn about the applicant's medical details. Significance: The practical and simple classification of workplaces according to the D‐system, and the concept of making medical information accessible only to OCPs may diminish stigma and discrimination in the working world for PWEs.


  • Open Access

    Multiple intracerebral hematomas during SEEG recording and intradural hemorrhage after spinal tap: A case report prompting more research on collagen IV gene mutation and oral nicotine consumption as risk factors

    by Markus Leitinger, Serena Broggi, Mathias Spendel, Gudrun Kalss, Ivan Petrović, Herbert Krainz, Fabio Rossini, Julia Höfler, Andreea Toma, Giorgi Kuchukhidze, et al.

    Intracerebral hemorrhages (ICH) during implantation of stereo‐EEG electrodes are rare. The impact of tobacco‐free nicotine consumption on periprocedural bleeding is uncertain. We present a 20+ year‐old man with drug‐resistant epilepsy who underwent stereo‐EEG with 17 depth electrodes. Within a few days after insertion, the patient developed multiple ICHs in the electrode trajectories and an intradural hemorrhage after a diagnostic spinal tap. We performed the investigation of the clotting system and whole‐exome sequencing (WES). WES identified a heterozygous mutation c.4698G>T, p.(Trp1566Cys) in COL4A2 (NM_001846.4) encoding a collagen type‐IV alpha‐2 chain inherited from his seemingly healthy mother. As COL4A2 mutations had been identified in four adult patients with ICH we postulated that the identified variant presents a potential risk factor. Notably, mutations encoding other collagens have been linked to cerebral hemorrhages (COL4A1) and increased propensity to trigger ICH upon smoking (COL1A2). Our patient consumed at least 24 oral nicotine pouches (containing 11 mg nicotine each) per day. We consider the patient's COL4A2 mutation in combination with his substantial nicotine consumption as likely predisposition to multiple ICHs precipitated by stereo‐EEG. Patients with nicotine consumption and any collagen mutation may have a substantially higher risk for hemorrhagic complications in SEEG and other neurosurgical procedures.Plain Language Summary: A young man with drug‐resistant epilepsy experienced multiple intracerebral hemorrhages after implantation of SEEG electrodes for presurgical evaluation and concomitantly a intradural hemorrhage after a lumbar spinal tap. A collagen IV mutation of unclear significance and heavy use of oral nicotine pouches were the only potential risk factors identified. As collagen mutations were previously described risk factors and smoking in particular worsens the bleeding risk in collagen mutations, further research is warranted to prevent hemorrhages in neurosurgical procedures. Nicotine consumption in any form is a preventable risk factor.


  • Open Access

    Ictal Cotard delusion as a manifestation of nonconvulsive status epilepticus: A case report and commentary

    by Bernardo Crespo Pimentel, Giorgi Kuchukhidze, Marta Heyduk, Aljoscha Thomschewski, Eugen Trinka, Julia Höfler

    Psychosis of epileptic origin can present a wide range of cognitive and affective symptoms and is often underrecognized. Usually occurring in the inter- and postictal phase, epileptic psychosis is mostly related to temporal lobe epilepsy. Here, we describe the clinical presentation and diagnostic workup including routine EEG recording and brain MRI of a 63-year-old woman expressing isolated nihilistic delusions comprising belief of being dead and denial of self-existence. EEG showed an ictal pattern fulfilling the Salzburg criteria of nonconvulsive status epilepticus and brain MRI revealed extensive peri-ictal hyperperfusion. Delusional symptoms and EEG abnormalities subsided after acute antiseizure treatment. Our case illustrates how nihilistic delusions can occur as a direct clinical correlate of seizure activity, thereby expanding the spectrum of ictal neuropsychiatric phenomena in temporal lobe epilepsy and highlighting the need to consider an epileptic origin in patients presenting with psychotic symptoms.


  • Open Access

    Sodium Valproate Modulates Cortical Morphology in Juvenile Myoclonic Epilepsy

    by Bernardo Crespo Pimentel, Giorgi Kuchukhidze, Fenglai Xiao, Lorenzo Caciagli, Julia Höfler, Lucas Rainer, Martin Kronbichler, Christian Vollmar, John S Duncan, Eugen Trinka, et al.

    Importance: Idiopathic generalized epilepsy syndromes in are associated with cortical thinning of the premotor areas. Whether this represents an underlying disease signature, a consequence of seizure activity or is related to anti-seizure medication is unknown. Objective: To investigate valproate-related effects on cortical morphology in people with juvenile myoclonic epilepsy (JME), one of the most common IGE syndromes. Design: Retrospective neuroimaging case-control study. Setting: Recruitment took place in epilepsy clinics in two European epilepsy referral centers. Participants: We matched individuals with JME on valproate ( n =36) to a group of healthy controls ( n =36), as well as individuals with JME not on valproate ( n =36) and a group of people with temporal lobe epilepsy ( n =19) on valproate using propensity scores for age, sex, occurrence of bilateral tonic-clonic seizures and drug refractoriness. Main outcomes and Measures: All participants underwent structural T1-weighted brain imaging and MRI-derived vertex-wise measurements of cortical thickness were calculated. Results were reported in effect-sizes using cohen’s d . Results: Compared to healthy controls, individuals with JME on valproate demonstrated cortical thinning bilaterally in the precentral gyri (left: d = -1.0, p <.001; right: d = -1.0, p <.001). This effect was localized to the left precentral gyrus when comparing JME on VPA with individuals with JME not on valproate ( d = -0.89; p <.01) or with individuals with temporal lobe epilepsy on valproate ( d = -0 . 18, p <.001). No significant differences in cortical thickness were detected between individuals with JME not on valproate and healthy controls. Cortical thinning in precentral gyrus, postcentral gyrus and superior frontal was more marked with increasing valproate dose (left: t = -6,65, p <.0001; right: t = -5,20, p <.0001). Conclusions and Relevance: In this cross-sectional study of 91 patients with epilepsy, valproate treatment was associated with JME-specific and dose-dependent cortical thinning of the precentral gyri. Our findings suggest a valproate-induced reorganization of disease-specific areas in JME that may not only help explain the high efficacy of this medication in IGEs but also potentially account for previously described changes of cortical thickness in this disease group.

  • Open Access

    Imaging Drug Resistance in Juvenile Myoclonic Epilepsy with MRI-derived Cortical Markers

    by Bernardo Crespo Pimentel, Giorgi Kuchukhidze, Fenglai Xiao, Lorenzo Caciagli, Julia Höfler, Lucas Rainer, Martin Kronbichler, Christian Vollmar, John S Duncan, Eugen Trinka, et al.

    Juvenile myoclonic epilepsy (JME) is the most common idiopathic generalized epilepsy (IGE) syndrome and can present a significant clinical challenge due to lack of seizure control and concomitant neuropsychological impairment. Its underlying mechanisms remain poorly understood. MRI studies have described structural changes in individuals with IGE syndromes but have so far not identified a distinct structural profile associated with drug resistant IGE. In this cross-sectional case-control neuroimaging analysis we included 79 participants with JME recruited at two European epilepsy centres, 43 of whom were drug resistant, as defined by recurrent seizures in the last 12 months despite adequate trials of at least two antiseizure medications (ASM), a drug sensitive group ( n =37), and 78 healthy controls. Participants underwent T1-weighted MRI and a comprehensive neuropsychological test battery including measures within two different domains: verbal memory and executive function. We performed vertex-wise measurements of cortical thickness and neurodevelopmental cortical measures, i.e. white matter surface area and local gyrification index (LGI), through a surface-based framework with subsequent correction of scanner-related effects. Group comparisons (family-wise error (FWE) corrected at p p Bonferroni p Bonferroni r < -0.75, p <0.01) after adjusting for disease duration and total ASM load. In conclusion, we identified a cognitive-developmental profile in drug resistant JME characterized by left-weighted changes in surface area and cortical folding complexity, the extent of which correlates with the degree of executive dysfunction. Our results shed further light onto the pathophysiological mechanisms of JME and suggest a neurodevelopmental/network basis for both drug refractoriness and cognitive impairment.


  • Open Access

    Recognition and perception of emotions in juvenile myoclonic epilepsy

    by Lucas Johannes Rainer, Giorgi Kuchukhidze, Eugen Trinka, Mario Braun, Martin Kronbichler, Patrick Langthaler, Georg Zimmermann, Lisa Kronbichler, Sarah Said‐Yürekli, Margarita Kirschner, et al.

    Objective: Perception and recognition of emotions are fundamental prerequisites of human life. Patients with juvenile myoclonic epilepsy (JME) may have emotional and behavioral impairments that might influence socially desirable interactions. We aimed to investigate perception and recognition of emotions in patients with JME by means of neuropsychological tests and functional magnetic resonance imaging (fMRI).Methods: Sixty-five patients with JME (median age = 27 years, interquartile range [IQR] = 23-34) were prospectively recruited at the Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria. Patients were compared to 68 healthy controls (median age = 24 years, IQR = 21-31), matched for sex, age, and education. All study participants underwent the Networks of Emotion Processing test battery (NEmo), an fMRI paradigm of "dynamic fearful faces," a structured interview for psychiatric and personality disorders, and comprehensive neuropsychological testing.Results: JME patients versus healthy controls demonstrated significant deficits in emotion recognition in facial and verbal tasks of all emotions, especially fear. fMRI revealed decreased amygdala activation in JME patients as compared to healthy controls. Patients were at a higher risk of experiencing psychiatric disorders as compared to healthy controls. Cognitive evaluation revealed impaired attentional and executive functioning, namely psychomotor speed, tonic alertness, divided attention, mental flexibility, and inhibition of automated reactions. Duration of epilepsy correlated negatively with parallel prosodic and facial emotion recognition in NEmo. Deficits in emotion recognition were not associated with psychiatric comorbidities, impaired attention and executive functions, types of seizures, and treatment.Significance: This prospective study demonstrated that as compared to healthy subjects, patients with JME had significant deficits in recognition and perception of emotions as shown by neuropsychological tests and fMRI. The results of this study may have importance for psychological/psychotherapeutic interventions in the management of patients with JME.


  • Open Access

    An international study of the effects of the COVID-19 pandemic on characteristics of functional seizures

    by Ali A. Asadi-Pooya, Eugen Trinka, Coraline Hingray, Ahmad Fawaz, Ioannis Karakis, Nirmeen A. Kishk, Mohsen Farazdaghi, Julia Höfler, Alexis Tarrada, Abdulaziz Ashkanani, et al.


  • Open Access

    (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study

    by Julia Höfler, Alexandra Rohracher, Gudrun Kalss, Georg Zimmermann, Judith Dobesberger, Georg Pilz, Markus Leitinger, Giorgi Kuchukhidze, Kevin Butz, Alexandra Taylor, et al.

    Objective The aim was to describe the safety and efficacy of (S)-ketamine [(S)-KET] in a series of patients with refractory and super-refractory status epilepticus (RSE and SRSE) in a specialized neurological intensive care unit (NICU). Methods We retrospectively analyzed the data of patients with RSE and SRSE treated with (S)-KET in the NICU, Salzburg, Austria, from 2011 to 2015. Data collection included demographic features, clinical presentation, diagnosis, electroencephalogram (EEG) data, anticonvulsant treatment, timing, and duration of treatment with (S)-KET. Outcomes were seizure control and death. Results A total of 42 patients (14 women) with RSE and SRSE were treated with (S)-KET. The median duration of status epilepticus (SE) was 10 days [first quartile (Q1) 5.0, Q3 21.0]; the median latency from SE onset to the first administration of (S)-KET was 3 days (Q1 2.0, Q3 6.8). Prior to (S)-KET administration, patients had received a median of two (Q1 2.0, Q3 3.0) anesthetics and three (Q1 2.0, Q3 4.0) antiepileptic drugs. Forty percent of patients (17/42) received propofol: 65 % prior to (S)-KET; 35 % at the same time with (S)-KET. Seven patients received a median bolus of (S)-KET of 200 mg (Q1 200, Q3 250) followed by a continuous infusion, while 35 started with a continuous infusion (maximum rate median 2.55 mg/kg/h; Q1 2.09, Q3 3.22). In 64 % of patients (27/42), (S)-KET was the last drug before SE cessation; in five patients, it was given with propofol at the same time. Median duration of administration was 4 days (Q1 2.0, Q3 6.8). Overall (S)-KET treatment was well tolerated, adverse effects were not observed, and overall mortality was 45.2 %. Conclusions Treatment of SRSE in adult patients with (S)-KET led to resolution of status in 64 %. No adverse events were found, indicating a favorable safety profile.